Stop Diabetic Complications
With Nervantage
Supports Diabetic Complications
- Blocks damage by Hyperglycemia
- Support for Diabetic Retinopathy
- Support for Diabetic Neuropathy
- Support for Diabetic Nephropathy
Great for These Non-Diabetic Conditions- Sciatica
- Heart/Vascular health
- Fibromyalgia
- Nerve Health-AntiAging
- Safe For Long Term Use
- Satisfaction Guaranteed
Benfotiamine, a synthetic variant of vitamin B1, can help prevent nerve and blood-vessel damage caused by diabetes. Three of the main complications of diabetes are nerve damage, circulatory difficulties and vision problems. These symptoms are caused by a build-up of sugar in the cells. Changes in insulin and glucose tolerance with age sometimes referred to as age-related diabetes similar symptoms have often been considered part of the aging process.
Now researchers have reported that Benfotiamine halts much of that sugar accumulation by boosting three pathways inside the cell. This could result in a vastly improved quality of life for those with the disease and those suffering the age-related symptoms.
References:
1. Hammes HP, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003 Mar;9(3):294-9.
2. Stracke H, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes. 2001;109(6):330-6.
benfotiamine Diabetes renal disease Polyneuropathy Neuropathy
NEW YORK (Reuters Health) Sept 22 - Benfotiamine prevents the endothelial dysfunction and oxidative stress that follow a meal rich in advanced glycation end (AGE) products in type 2 diabetics, according to a report in the September issue of Diabetes Care.
"Benfotiamine was used for decades as a treatment of diabetic neuropathy, without any exact knowledge of the beneficial mechanism," Dr. Alin Stirban from Ruhr-University, Bochum, Germany told Reuters Health. "Our data bring benfotiamine from the relatively restricted field of diabetic neuropathy into the much larger field of vascular function and prove in humans effects previously postulated."
Dr. Stirban and colleagues investigated the effects of a real-life, cooked, AGE-rich meal on endothelial function and oxidative stress with or without benfotiamine pretreatment in 13 adults with type 2 diabetes.
The high-AGE meal significantly impaired endothelium-dependent vasodilatation, the authors report, but this impairment was completely prevented by benfotiamine.
The high-AGE meal, with or without benfotiamine pretreatment, did not affect endothelium-independent vasodilatation, the results indicate.
Benfotiamine pretreatment also prevented the decrease in reactive hyperemia and the increase in circulating markers of endothelial dysfunction, inflammation, and oxidative stress seen after a high-AGE meal, the researchers note. The beneficial effects of benfotiamine treatment were accompanied by lower serum levels of AGEs and dicarbonyls, the report indicates.
"Our study does not completely elucidate the mechanisms through which benfotiamine prevents postprandial vascular dysfunction but raises some hypotheses," the authors conclude. "Further studies are warranted to bring light into these subtle mechanisms."
"We intend to investigate in a placebo-controlled manner medium-term effects of benfotiamine on endothelial function," Dr. Stirban said. "But we will extend our observation also on other cell types of critical importance for people with diabetes, such as adipocytes."
Diabetes Care 2006;29:2064-2071
|
